BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17180576)

  • 1. Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor.
    Kurz K; Voelker R; Zdunek D; Wergeland R; Hess G; Ivandic B; Katus H; Giannitsis E
    Clin Res Cardiol; 2007 Mar; 96(3):152-9. PubMed ID: 17180576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.
    Sabatine MS; Morrow DA; de Lemos JA; Omland T; Desai MY; Tanasijevic M; Hall C; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2004 Nov; 44(10):1988-95. PubMed ID: 15542281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [N-terminal pro-brain natriuretic peptide (NT-proBNP) and ischemia modified albumin (IMA) in exercise induced ischemia in patients with stable coronary artery disease].
    Piechota WN; Wierzbowski R; Piechota WT; Bejm J; Gielerak G
    Pol Arch Med Wewn; 2006 Jul; 116(1):640-7. PubMed ID: 17340970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides.
    Foote RS; Pearlman JD; Siegel AH; Yeo KT
    J Am Coll Cardiol; 2004 Nov; 44(10):1980-7. PubMed ID: 15542280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
    Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
    Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.
    Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of changes in B-type natriuretic peptides to detect ischemia in selected patients.
    Staub D; Jauslin D; Freidank H; Taegtmeyer A; Breidthardt T; Zellweger MJ; Mueller-Brand J; Christ M; Mueller C
    Int J Cardiol; 2009 Jul; 136(1):40-6. PubMed ID: 18632168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NT-pro-BNP is associated with inducible myocardial ischemia in mildly symptomatic type 2 diabetic patients.
    Wiersma JJ; van der Zee PM; van Straalen JP; Fischer JC; van Eck-Smit BLF; Tijssen JGP; Trip MD; Piek JJ; Verberne HJ
    Int J Cardiol; 2010 Nov; 145(2):295-296. PubMed ID: 19900726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia.
    Staub D; Jonas N; Zellweger MJ; Nusbaumer C; Wild D; Pfisterer ME; Mueller-Brand J; Perruchoud AP; Mueller C
    Am J Med; 2005 Nov; 118(11):1287. PubMed ID: 16271916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT-BNP) to acute myocardial infarction.
    Gill D; Seidler T; Troughton RW; Yandle TG; Frampton CM; Richards M; Lainchbury JG; Nicholls G
    Clin Sci (Lond); 2004 Feb; 106(2):135-9. PubMed ID: 12974669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
    Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
    Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with spect perfusion imaging.
    Zaid G; Tanchilevitch A; Rivlin E; Gropper R; Rosenschein U; Lanir A; Goldhammer E
    Int J Cardiol; 2007 Apr; 117(2):157-64. PubMed ID: 16997398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic peptide predicts myocardial ischemia and is related to postischemic left-ventricular dysfunction in patients with stable coronary artery disease.
    Vanzetto G; Jacon P; Calizzano A; Neuder Y; Faure P; Fagret D; Machecourt J
    J Nucl Cardiol; 2007; 14(6):835-42. PubMed ID: 18022110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease.
    Montagnana M; Lippi G; Fava C; Minuz P; Santonastaso CL; Arosio E; Guidi GC
    Clin Chem Lab Med; 2006; 44(2):207-12. PubMed ID: 16475909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dipyridamole stress echocardiography on galectin-3, amino-terminal B-type natriuretic peptide (NT-proBNP) and high-sensitivity troponin T.
    Lippi G; Salvagno GL; Robuschi F; Scioscioli F; Ruffini L; Cervellin G
    Acta Cardiol; 2014 Aug; 69(4):377-83. PubMed ID: 25181912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides.
    Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C
    Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stronger correlation with myocardial ischemia of high-sensitivity troponin T than other biomarkers.
    Pipikos T; Kapelouzou A; Tsilimigras DI; Fostinis Y; Pipikou M; Theodorakos A; Pavlidis AN; Kontogiannis C; Cokkinos DV; Koutelou M
    J Nucl Cardiol; 2019 Oct; 26(5):1674-1683. PubMed ID: 29380285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
    Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
    Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.